Accretion Nutraveda Limited (BSE: 544694) is an Ahmedabad, Gujarat-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹256 Cr, it ranks #2,447 by market cap among the 6,197 Indian listed companies on FinBizNet, and #10 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹348.80 (as of 16 Nov 2026), the share price is 3.1% below its 52-week high of ₹360.00 and 132.4% above its 52-week low of ₹150.10.
| Current Price | ₹348.80 |
|---|---|
| Market Cap | ₹256 Cr |
| BSE Code | 544694 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Contract Manufacturing Services |
| P/E Ratio | 37.7 |
| Return on Assets | 15.88% |
| 52-Week Range | ₹150.10 – ₹360.00 |
| 3-Month Price Change | +16.7% |
| Beta (1Y) | -0.14 |
| Headquarters | Ahmedabad, Gujarat |
| Website | accretionnutraveda.com |
Delivery averaged 87.0% of traded volume across 9 BSE sessions (23 Oct 2026 – 13 Nov 2026).
Accretion Nutraveda Limited manufactures and sells ayurvedic and nutraceutical products in India and Internationally. The company focuses on ayurvedic and nutraceutical products, including tablets, capsules, oral liquids, oral powders, external preparations, and oils. Its product portfolio includes tablets, such as film-coated and chewable varieties, for applications in liver care, gynecological care, bone and joint health, and respiratory support; capsules comprising hard gelatin and HPMC capsules, targeting areas like liver detoxification, women’s health, and cognitive support; and oral liquids, including syrups, suspensions, and tonics, which are particularly suited for paediatric and geriatric. It offers products for bone and joint care, respiratory care, gynec care, digestive care, cardiac care, liver care, paediatric care, skin and hair care, urinary and UTI care, baby care products, and memory and neuron care. The company also operates as a healthcare-focused contract developmen
1. Manufacturing and Sale of Pharmaceutical Products-This segment manufactures and sells ayurvedic and nutraceutical products. 2. NA-NA 3. NA-NA 4. NA-NA
1. Manufacturing and Sale of Pharmaceutical Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Torrent Pharma Ltd. | ₹1,79,494 Cr | 73.6 | 16.98% | ₹4,979 Cr | +30.4% |
| Aether Industries Limited | ₹21,710 Cr | 101.8 | 9.81% | ₹347 Cr | +127.8% |
| Alivus Life Sciences Ltd | ₹17,862 Cr | 31.5 | 18.36% | ₹682 Cr | +64.0% |
| Aarti Pharmalabs Ltd | ₹8,374 Cr | 52.5 | 8.49% | ₹610 Cr | +15.4% |
| Solara Active Pharma Sciences Limited | ₹3,225 Cr | n/m | -0.63% | ₹417 Cr | +22.1% |
| Sai Parenteral's Limited | ₹2,235 Cr | 115.8 | 2.88% | ₹195 Cr | — |
| KRM Ayurveda Limited | ₹521 Cr | 25.9 | 17.54% | ₹32 Cr | — |
| Trident Lifeline Limited | ₹511 Cr | 26 | — | — | +37.6% |
| Accretion Nutraveda Limited | ₹256 Cr | 37.7 | — | — | — |
Listed by market capitalisation. Ratios are shown for context only.
Accretion Nutraveda Limited is trading at ₹348.80, with a market capitalisation of ₹256 Cr.
Accretion Nutraveda Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).
Accretion Nutraveda Limited has a P/E of 37.7.
Accretion Nutraveda Limited is listed on the BSE under the scrip code 544694.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.